日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Erythropoietin receptor upregulation is associated with tubular injury severity in human acute kidney injury.

红细胞生成素受体上调与人类急性肾损伤中的肾小管损伤严重程度相关。

期刊:Renal Failure
影响因子:3
doi:10.1080/0886022X.2026.2650260
Xie Kun, Zhou Gang, Li Mengjin, Fu Lili, Wang Rong, Zhang Liming, Mei Changlin, Xue Cheng, Xu Daoliang
肾损伤
信号转导
红细胞
细胞生物学
毒理研究
发表日期：2026
文献求助 收藏

Immune microenvironment in autosomal dominant polycystic kidney disease

常染色体显性多囊肾病中的免疫微环境

期刊:Genes and Diseases
影响因子:
doi:10.1016/j.gendis.2025.101694
Xue, Cheng; Li, Xinming; Zhou, Chenchen; Mei, Changlin; Mao, Zhiguo
免疫/内分泌
发表日期：2026
文献求助 收藏

D-glucuronyl C5-Epimerase Binds to EGFR to Suppress Kidney Fibrosis

D-葡萄糖醛酸C5-差向异构酶与EGFR结合以抑制肾纤维化

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202416216
Jing, Xiaoqi; Wu, Jun; Ning, Jingru; Ding, Xiaoyu; Du, Zhenyun; Wang, Xiaojiang; Huang, Lulin; Wang, Ran; Mei, Changlin; Ding, Kan
EGFR
EGF
发表日期：2025
文献求助 收藏

Correction: Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction

更正：概述培莫沙肽通过EPOR介导的信号转导发挥长期促红细胞生成作用的临床前和II期临床研究

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06632-x
Ma, Xiaoying; Li, Zhen; Zhang, Lu; Qian, Hui; Chen, Qinkai; Tao, Ye; Li, Yunfan; Wang, Dandan; Hu, Zhizhen; Luo, Weili; Li, Ping; Yu, Hai; Mei, Changlin; Yu, Xueqing; Zhou, Yuanfeng
信号转导
EPOR
红细胞
EPO
细胞生物学
发表日期：2025
文献求助 收藏

Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study

HSK21542 在血液透析患者中的安全性和有效性：一项多剂量递增研究

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1203642
Pan, Mingming; Wang, Guihua; Zhou, Li; Xu, Yan; Yao, Li; Wu, Chaoqing; Mei, Changlin; Zhao, Zhanzheng; Sun, Dong; Guan, Tianjun; Chen, Qinkai; Shi, Ming; Xu, Hui; Zeng, Weifang; Li, Fangqiong; Yan, Rui; Liu, Bi-Cheng
发表日期：2023
文献求助 收藏

Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1

糖尿病肾纤维化的易感性：缺氧诱导因子-1的作用

期刊:FASEB Journal
影响因子:4.2
doi:10.1096/fj.202200845R
Mei, Shuqin; Li, Lin; Zhou, Xiangjun; Xue, Cheng; Livingston, Man J; Wei, Qingqing; Dai, Bing; Mao, Zhiguo; Mei, Changlin; Dong, Zheng
糖尿病
代谢
发表日期：2022
文献求助 收藏

In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study

中心夜间血液透析降低了循环FGF23水平、左心室肥厚和全因死亡率：一项回顾性队列研究

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2022.912764
Kang, Meizi; Chen, Jing; Liu, Lingling; Xue, Cheng; Tang, Xiaojing; Lv, Jiayi; Fu, Lili; Mei, Changlin; Mao, Zhiguo; Liu, Yawei; Dai, Bing
FGF2
发表日期：2022
文献求助 收藏

Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease

常染色体显性多囊肾病中的染色质甲基化异常

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2022.921631
Xu, Jing; Xue, Cheng; Wang, Xiaodong; Zhang, Lei; Mei, Changlin; Mao, Zhiguo
表观遗传
DNA甲基化
发表日期：2022
文献求助 收藏

A Nomogram to Identify Hyperkalemia Risk in Patients with Advanced CKD

用于识别晚期慢性肾脏病患者高钾血症风险的列线图

期刊:Kidney360
影响因子:3
doi:10.34067/KID.0004752022
Xue, Cheng; Zhou, Chenchen; Yang, Bo; Ye, Xiaofei; Xu, Jing; Lu, Yunhui; Hu, Xiaohua; Chen, Jia; Luo, Xiaoling; Zhang, Liming; Mei, Changlin; Mao, Zhiguo
发表日期：2022
文献求助 收藏

Thrombotic thrombocytopenic purpura developed after pegylated interferon treatment for hepatitis B infection

乙型肝炎感染患者接受聚乙二醇干扰素治疗后出现血栓性血小板减少性紫癜

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-022-03034-9
Mei, Shuqin; Feng, Yun; Cui, Linlin; Chen, Jing; Mao, Zhiguo; Zhao, Xuezhi; Mei, Changlin; Qian, Yixin
炎症/感染
心血管
肝炎
血小板
发表日期：2022
文献求助 收藏